ACCENTIA BIOPHARMACEUTICALS INC — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5573ff2c-248e-48aa-93ff-6c15a8cf4f2a/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2012 | $-11.5M | 2011-10-01 – 2012-09-30 | evidence 0001193125-12-514944 |
| FY 2011 | $-21.2M | 2010-10-01 – 2011-09-30 | evidence 0001193125-11-345824 |
| FY 2010 | $-3.6M | 2009-10-01 – 2010-09-30 | evidence 0001193125-11-345824 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).